Abstract

Objective: Hereditary Angioedema (HAE) is a rare but life-threatening disease. It is aimed to present data on the clinical characteristics of our pediatric patients with HAE, whose symptoms usually start in childhood, but the delay in diagnosis is still a serious problem.

Method: Clinical and laboratory findings, family histories, and clinical characteristics of 14 patients with HAE diagnosed in our clinic between 1998-2019 were analyzed.

Results: Half of our patients diagnosed with HAE were girls, 78.5% of them were diagnosed with HAE type 1, and 21.4% were HAE type 2. All our patients had a family history, and 10 of them were diagnosed based on their family history. The mean age at diagnosis was 9.7±4.4 years and the mean age at the onset of the first angioedema symptom was 5.3±1.8 years. The delay in diagnosis was 4.4±4.1 years. The swollen areas included extremities (78.5%), abdominal attacks (71.4%), facial edema (57.1%), and laryngeal edema (21.4%). C4 levels were low in all patients. The mean C1 esterase inhibitor level was 0.69±0.08 g/l for HAE type 2 and 0.08±0.04 g/l for HAE type 1. The mean C1 esterase inhibitor functional activity level was 18.6±10.4% in HAE type 2.

Conclusion: Early diagnosis of the disease is critical for reducing morbidity and mortality due to attacks. There are very few studies in Türkiye that focus exclusively on pediatric HAE patients. Sharing our patients’ clinical findings and treatment plans for this rare disease is crucial for bringing the disease to light and raising awareness.

Keywords: Hereditary angioedema, pediatric, clinical trial

Copyright and license

Copyright © 2023 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Bölük SÖ, Can D, Gülez N, Karkıner CŞ, Soyöz Ö, Çelebi Çelik F, et al. Symptoms, clinical profile and management of pediatric hereditary angioedema: A single-centre experience. Trends in Pediatrics. 2023;4(3):192-198. https://doi.org/10.59213/TP.2023.09815

References

  1. Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021;9:132-50.e3. https://doi.org/10.1016/j.jaip.2020.08.046
  2. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med. 1996;334:1666-7. https://doi.org/10.1056/NEJM199606203342510
  3. Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1992;71:206-15. https://doi.org/10.1097/00005792-199207000-00003
  4. Sabharwal G, Craig T. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). Expert Rev Clin Immunol. 2015;11:319-27. https://doi.org/10.1586/1744666X.2015.1012502
  5. De Maat S, Hofman ZLM, Maas C. Hereditary angioedema: the plasma contact system out of control. J Thromb Haemost. 2018;16:1674-1685. https://doi.org/10.1111/jth.14209
  6. Mete Gökmen N, Gülbahar O, Onay H, et al. Deletions in SERPING1 lead to lower C1 inhibitor function: lower C1 inhibitor function can predict disease severity. Int Arch Allergy Immunol. 2019;178:50-9. https://doi.org/10.1159/000492583
  7. Busse PJ, Christiansen SC. Hereditary angioedema. N Engl J Med. 2020;382:1136-48. https://doi.org/10.1056/NEJMra1808012
  8. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602-16. https://doi.org/10.1111/all.12380
  9. Rosi-Schumacher M, Shah SJ, Craig T, Goyal N. Clinical manifestations of hereditary angioedema and a systematic review of treatment options. Laryngoscope Investig Otolaryngol. 2021;6:394-403. https://doi.org/10.1002/lio2.555
  10. Nanda MK, Elenburg S, Bernstein JA, Assa'ad AH. Clinical features of pediatric hereditary angioedema. J Allergy Clin Immunol Pract. 2015;3:392-5. https://doi.org/10.1016/j.jaip.2014.11.012
  11. Zanichelli A, Magerl M, Longhurst H, Fabien V, Maurer M. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin Immunol. 2013;9:29. https://doi.org/10.1186/1710-1492-9-29
  12. Kesim B, Uyguner ZO, Gelincik A, et al. The Turkish Hereditary Angioedema Pilot Study (TURHAPS): the first Turkish series of hereditary angioedema. Int Arch Allergy Immunol. 2011;156:443-50. https://doi.org/10.1159/000323915
  13. Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003;163:1229-35. https://doi.org/10.1001/archinte.163.10.1229
  14. Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130:692-7. https://doi.org/10.1016/j.jaci.2012.05.055
  15. Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009;161:1153-8. https://doi.org/10.1111/j.1365-2133.2009.09366.x
  16. Andrási N, Balla Z, Visy B, et al. Diagnosing pediatric patients with hereditary C1-inhibitor deficiency-experience from the Hungarian angioedema center of reference and excellence. Front Allergy. 2022;3:860355. https://doi.org/10.3389/falgy.2022.860355
  17. Anon JB. Hereditary angioedema: a clinical review for the otolaryngologist. Ear Nose Throat J. 2011;90:32-9. https://doi.org/10.1177/014556131109000822
  18. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-74. https://doi.org/10.1016/j.amjmed.2005.09.064
  19. Piotrowicz-Wójcik K, Porebski G. Life-threatening laryngeal attacks in hereditary angioedema patients. Otolaryngol Pol. 2020;74:1-5. https://doi.org/10.5604/01.3001.0014.0619
  20. Ocak M, Nain E, Şahiner ÜM, et al. Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema? Pediatr Dermatol. 2021;38:143-8. https://doi.org/10.1111/pde.14467
  21. Farkas H, Kőhalmi KV, Visy B, Veszeli N, Varga L. Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema-a long-term survey. J Allergy Clin Immunol Pract. 2020;8:2379-83. https://doi.org/10.1016/j.jaip.2020.02.043